e-learning
resources
Vienna 2012
Sunday, 02.09.2012
Asthma: risk factors and effect of anti-IgE
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Analysis of IL-6 function in transmaternal asthma protection induced by Acinetobacter Iwoffii
D.A. Kesper, O. Pinkenburg, P.I. Pfefferle, H. Garn, H. Renz (Marburg, Germany)
Source:
Annual Congress 2012 - Asthma: risk factors and effect of anti-IgE
Session:
Asthma: risk factors and effect of anti-IgE
Session type:
Poster Discussion
Number:
231
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D.A. Kesper, O. Pinkenburg, P.I. Pfefferle, H. Garn, H. Renz (Marburg, Germany). Analysis of IL-6 function in transmaternal asthma protection induced by Acinetobacter Iwoffii. Eur Respir J 2012; 40: Suppl. 56, 231
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Interleukin-6 is important for the development of Acinetobacter lwoffii-mediated protection against asthma
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018
Acinetobacter lwoffii
and
lactococcus lactis
strains isolated from cowsheds of traditional farms suppress allergic airway inflammation in a mouse model of experimental asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 736s
Year: 2007
Therapeutic intratracheal phage application against Acinetobacter baumannii lung infection in mice
Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies
Year: 2018
Acinetobacter baumanii and Stenotrophomonas maltophilia are associated with lower airway infections in tracheostomised children and young adults.
Source: International Congress 2017 – New insights into paediatric respiratory infections
Year: 2017
IL-10 induced T-cell tolerance to
Aspergillus fumigatus
and
Pseudomonas aeruginosa
in cystic fibrosis
Source: Eur Respir J 2001; 18: Suppl. 33, 8s
Year: 2001
Chlamydia pneumoniae enhances infection with Haemophilus influenzae, up-regulates TLR2-expression in human lung tissue and leads to enhanced chemokine production after coinfection – a possible mechanism for COPD exacerbations
Source: Annual Congress 2008 - New diagnostic methods in viral and atypical infections
Year: 2008
Mechanisms of induction of neutrophil apoptosis by the pseudomonas aeruginosa exotoxin pyocyanin
Source: Eur Respir J 2004; 24: Suppl. 48, 107s
Year: 2004
Acinetobacter baumani
and
Pseudomonas aeruginosa
drug susceptibility after bacteriological analysis of sputum in patients mechanically ventilated in ICU
Source: Eur Respir J 2003; 22: Suppl. 45, 450s
Year: 2003
Experimental Pseudomonas aeruginosa pneumonia: evaluation of the associated inflammatory response
Source: Eur Respir J 2007; 30: 1167-1172
Year: 2007
Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with COPD.
Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Year: 2020
Clinical profile and outcome of patients with sputum positive Acinetobacter baumanni infection
Source: International Congress 2018 – Difficult-to-treat respiratory infections
Year: 2018
Novel swine ARDS model induced by Pseudomonas aeruginosa pneumonia and VILI
Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine
Year: 2020
In vivo
evidence for aspergillus fumigatus and pseudomonas aeruginosa driven th-17 type inflammatory responses in the lungs of CF-patients
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009
Acinetobacter baumanii
as a severity marker in a respiratory ICU
Source: Eur Respir J 2006; 28: Suppl. 50, 786s
Year: 2006
Characterization of the resistance mechanisms to carbapenems and virulence genes in Pseudomonas aeruginosa strains from children with cystic fibrosis.
Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects
Year: 2021
Association of IL-8 A-251T polymorphism with
Pseudomonas aeruginosa
infection and lung function decline in children with CF
Source: Eur Respir J 2005; 26: Suppl. 49, 726s
Year: 2005
IL-6 and IL-8 production induced by Pseudomonas aeruginosa flagellin in human bronchial epithelial cells.
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017
Human airway epithelial cell response to
Pseudomonas aeruginosa
virulence factors preceded or not by
Staphylococcus aureus
Source: Eur Respir J 2006; 28: Suppl. 50, 191s
Year: 2006
Azithromycin protects bronchial epithelial integrity after
Pseudomonas aeruginosa
infection independent of bactericidal activity
Source: Annual Congress 2008 - Best of lung epithelial cells 2008
Year: 2008
Effects of direct lung dosing of Tobramycin in a rat chronic infection model using Pseudomonas aeruginosa RP73
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept